Five-Year outcomes of patients enrolled in the REVEAL Registry.
Farber HW, Miller DP, Poms AD, Badesch DB, Frost AE, Muros-Le Rouzic E, Romero AJ, Benton WW, Elliott CG, McGoon MD, Benza RL.
Farber HW, et al. Among authors: miller dp.
Chest. 2015 Oct;148(4):1043-54. doi: 10.1378/chest.15-0300.
Chest. 2015.
PMID: 26066077
Free article.
Clinical Trial.
The present study characterizes the 5-year survival in the United States of a new and previous diagnosis of PAH in patients stratified by baseline functional class (FC). The Registry to Evaluate Early and Long-term PAH Disease Management (REVEAL Registry) is a 55-center ob …
The present study characterizes the 5-year survival in the United States of a new and previous diagnosis of PAH in patients stratified by ba …